Atlas Trials

Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC

Clinical trial NCT00544453 · TERMINATED

Trial details

NCT number
NCT00544453
Sponsor
Molecular NeuroImaging
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2007-10-01
Primary completion
2007-10-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.